Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11432668rdf:typepubmed:Citationlld:pubmed
pubmed-article:11432668lifeskim:mentionsumls-concept:C1319315lld:lifeskim
pubmed-article:11432668lifeskim:mentionsumls-concept:C0596290lld:lifeskim
pubmed-article:11432668lifeskim:mentionsumls-concept:C0006233lld:lifeskim
pubmed-article:11432668lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:11432668lifeskim:mentionsumls-concept:C0016263lld:lifeskim
pubmed-article:11432668lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:11432668lifeskim:mentionsumls-concept:C0243144lld:lifeskim
pubmed-article:11432668lifeskim:mentionsumls-concept:C0021044lld:lifeskim
pubmed-article:11432668lifeskim:mentionsumls-concept:C0442726lld:lifeskim
pubmed-article:11432668pubmed:issue6lld:pubmed
pubmed-article:11432668pubmed:dateCreated2001-7-2lld:pubmed
pubmed-article:11432668pubmed:abstractTextWe compared three different means of assaying tumor proliferative activity in 30 human colorectal adenocarcinomas labeled in vivo with bromodeoxyuridine (BrdUrd). The labeling indices (LI) of BrdUrd obtained both by flow cytometry (FCM) and immunohistochemistry (IH) were also compared with the labeling index of Ki-67. These methods were then related to tumor ploidy and pathological features. Flow cytometry was performed in accordance with Begg's method after intravenous infusion of BrdUrd four hours before surgery. Immunohistology was carried out on paraffin-embedded sections with monoclonal antibodies against BrdUrd and Ki-67. A positive correlation was found between BrdUrd LI obtained by both FMC and IH (p<0.0001), a finding that complies with the literature. However, we report on a correlation between Ki-67 LI and BrdUrd LIs in colorectal tumors (p=0.012). The results were valid for all tumors when they were subdivided into diploid and aneuploid groups. The labeling indices were significantly higher in the aneuploid tumor group than in the diploid group (p=0.047). No relationship between proliferation parameters and tumor stage or grade was found. To our knowledge, this is the first report on a positive correlation between tumor proliferation indices in BrdUrd LIs and Ki-67 in colorectal carcinomas. This finding validates the value of Ki-67 immunostaining, which, however, should be confirmed in a larger series under the same technical conditions.lld:pubmed
pubmed-article:11432668pubmed:languageenglld:pubmed
pubmed-article:11432668pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11432668pubmed:citationSubsetIMlld:pubmed
pubmed-article:11432668pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11432668pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11432668pubmed:statusMEDLINElld:pubmed
pubmed-article:11432668pubmed:issn0344-0338lld:pubmed
pubmed-article:11432668pubmed:authorpubmed-author:HellotM FMFlld:pubmed
pubmed-article:11432668pubmed:authorpubmed-author:HemetJJlld:pubmed
pubmed-article:11432668pubmed:authorpubmed-author:PaillotBBlld:pubmed
pubmed-article:11432668pubmed:authorpubmed-author:LemoineFFlld:pubmed
pubmed-article:11432668pubmed:authorpubmed-author:MichelPPlld:pubmed
pubmed-article:11432668pubmed:authorpubmed-author:ScottiAAlld:pubmed
pubmed-article:11432668pubmed:authorpubmed-author:PeillonCClld:pubmed
pubmed-article:11432668pubmed:authorpubmed-author:ParesyMMlld:pubmed
pubmed-article:11432668pubmed:authorpubmed-author:Le PessotFFlld:pubmed
pubmed-article:11432668pubmed:issnTypePrintlld:pubmed
pubmed-article:11432668pubmed:volume197lld:pubmed
pubmed-article:11432668pubmed:ownerNLMlld:pubmed
pubmed-article:11432668pubmed:authorsCompleteYlld:pubmed
pubmed-article:11432668pubmed:pagination411-8lld:pubmed
pubmed-article:11432668pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11432668pubmed:meshHeadingpubmed-meshheading:11432668...lld:pubmed
pubmed-article:11432668pubmed:meshHeadingpubmed-meshheading:11432668...lld:pubmed
pubmed-article:11432668pubmed:meshHeadingpubmed-meshheading:11432668...lld:pubmed
pubmed-article:11432668pubmed:meshHeadingpubmed-meshheading:11432668...lld:pubmed
pubmed-article:11432668pubmed:meshHeadingpubmed-meshheading:11432668...lld:pubmed
pubmed-article:11432668pubmed:meshHeadingpubmed-meshheading:11432668...lld:pubmed
pubmed-article:11432668pubmed:meshHeadingpubmed-meshheading:11432668...lld:pubmed
pubmed-article:11432668pubmed:meshHeadingpubmed-meshheading:11432668...lld:pubmed
pubmed-article:11432668pubmed:meshHeadingpubmed-meshheading:11432668...lld:pubmed
pubmed-article:11432668pubmed:meshHeadingpubmed-meshheading:11432668...lld:pubmed
pubmed-article:11432668pubmed:meshHeadingpubmed-meshheading:11432668...lld:pubmed
pubmed-article:11432668pubmed:meshHeadingpubmed-meshheading:11432668...lld:pubmed
pubmed-article:11432668pubmed:meshHeadingpubmed-meshheading:11432668...lld:pubmed
pubmed-article:11432668pubmed:meshHeadingpubmed-meshheading:11432668...lld:pubmed
pubmed-article:11432668pubmed:year2001lld:pubmed
pubmed-article:11432668pubmed:articleTitleCell proliferation in colorectal adenocarcinomas: comparison between Ki-67 immunostaining and bromodeoxyuridine uptake detected by immunohistochemistry and flow cytometry.lld:pubmed
pubmed-article:11432668pubmed:affiliationDepartment of Pathology, Rouen University Hospital Charles Nicolle, France. AHU2.Anatomie.Pathologie@chu-rouen.frlld:pubmed
pubmed-article:11432668pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11432668pubmed:publicationTypeComparative Studylld:pubmed